Portland-based biotech ImmuCell posts 45% sales increase for Q4

ImmuCell Corp. (Nasdaq: ICCC), a Portland-based biotech company that makes health products for cattle, last week posted double-digit sales increases for both the fourth quarter and full year of 2021. The company also shrank its net loss for the year.

During the three-month period ended Dec. 31, 2021, sales grew by 45%, or $1.7 million, over the same period a year earlier, to $5.4 million. Sales for all of 2021 increased by 25%, or $3.9 million, over 2020 to $19.2 million. Read more

Related Posts

University of Maine recruiting homeowners for tick surveys

ORONO, Maine — With tick season upon us, researchers at the University of Maine want to know what Mainers are doing...

25 April 2023

Maine’s oldest bioscience symposium turns 50 on MDI

Students and accomplished science leaders share research on Mt. Desert Island This April 20 marked the 50th anniversary meeting of the...

23 April 2023

Husson University students, faculty share projects at 13th annual Research Showcase

BANGOR, Maine — Today marked Husson University’s 13th annual Research and Scholarship Day. Students and faculty members at Husson shared the...

20 April 2023